nytimes August 12, 2021 7:01pm F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder #drugspharmaceuticals #sedatives #narcolepsy #sleep #foodanddrugadministration #jazzpharmaceuticalsinc #drugabuseandtraffic #science #news F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar.
